1 Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. Aimaz.afrough@utsouthwestern.edu.
2 Medical University of South Carolina, Charleston, SC, USA.
3 H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
4 Stanford University School of Medicine, Stanford, CA, USA.
5 Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA.
6 Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.
7 University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
8 Levine Cancer Institute, Charlotte, NC, USA.
9 The University of Kansas Medical Center, Kansas City, KS, USA.
10 Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA.
11 The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
12 Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
13 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
14 City of Hope National Medical Center, Duarte, CA, USA.
15 Dana-Farber Cancer Institute, Boston, MA, USA.
16 Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. larry.anderson@utsouthwestern.edu.